# Why Boston Scientific stands out today

Boston Scientific (BSX), In the Sweet Spot pick for August 11, 2026: Boston Scientific sits 54% below its 52-week high with a PAR near the top of the sweet s...

Canonical: https://www.manifestinvesting.com/sweet-spot/bsx-boston-scientific-2026-08-11

In the Sweet Spot · August 11, 2026 · Boston Scientific (BSX) · Healthcare

**Boston Scientific sits 54% below its 52-week high with a PAR near the top of the sweet spot, pairing an elite quality profile with a projected return that reflects the market's repricing of the shares.**

Boston Scientific (BSX) was Manifest Investing's In the Sweet Spot daily stock pick for August 11, 2026. At the time of the pick, Boston Scientific carried a quality percentile of 99 and a projected annual return (PAR) of 18.5% against a MIPAR of 8.9%, placing it inside the sweet spot of 13.9% to 18.9%.

## Key metrics at the time of the pick

- **Quality percentile**: 99
- **Projected annual return (PAR)**: 18.5%
- **MIPAR (median PAR of coverage)**: 8.9%
- **PROVE**: 13.5%
- **Core score (of 300)**: 291
- **Financial strength (of 100)**: 97
- **EPS stability (of 100)**: 94.4
- **Sales growth forecast**: 10.9%
- **P/E ratio**: 20.6
- **Price at pick**: $50.46
- **52-week low**: $42.20
- **52-week high**: $109.50
- **Above 52-week low**: 19.6%
- **Below 52-week high**: 53.9%
- **Dividend yield**: 0.0%
- **Projected yield**: 0.0%
- **In the sweet spot**: Yes
- **Triple play**: No

## Boston Scientific (BSX)

| \*\*Quality 99.4 | PAR 18.5% | Core Score 291/300 | Price $50.46\*\* |

With MIPAR (the median projected annual return across all stocks Manifest tracks) at 8.9%, the sweet spot band runs from 13.9% to 18.9%. Boston Scientific’s projected annual return of 18.5% sits near the top of that range, paired with a quality percentile of 99.4 — among the highest in our coverage. Financial strength ranks 97.3 out of 100 and EPS stability sits at 94.4, both elite readings, while the growth forecast behind the projection is a comparatively modest 10.9% annually. The sum of quality, financial strength, and EPS stability (core score) is 291, well above the 225 threshold many long-term investors use as a “core holding” screen.

### Why the return projection is elevated right now

PAR moves inversely to price: when a high-quality company’s price falls sharply while its underlying fundamentals hold up, the projected return rises. BSX’s current price of $50.46 is 53.9% below its 52-week high of $109.50 (52-week range: $42.20–$109.50). That combination — a steep pullback alongside still-strong quality and financial-strength scores — is the textbook setup this feature exists to surface: not a claim that the stock is “cheap” in some absolute sense, but a data point worth studying because the market has repriced the shares meaningfully lower.

### Bottom line for research purposes

Boston Scientific pairs an elite quality and core score profile with a PAR near the top of the sweet spot, a dynamic directly tied to a 54% pullback from its 52-week high. Understanding why the market has repriced the shares this much is exactly the kind of question worth digging into further — the fundamentals and valuation reset make this a company worth a closer look, not a buy or sell signal in themselves.

_This is an educational highlight, not a recommendation. As always, weigh any decision against your own goals, risk tolerance, and further research._

Boston Scientific has also been the In the Sweet Spot pick on: [September 11, 2026](/sweet-spot/bsx-boston-scientific-2026-09-11).

## About In the Sweet Spot

Manifest Investing's daily stock pick: one high-quality company whose projected annual return (PAR) sits in the sweet spot above the market median (MIPAR). Each pick pairs Manifest Investing's quality percentile with its projected annual return (PAR); the sweet spot runs from MIPAR + 5 to MIPAR + 10 percentage points. Browse [every pick in the archive](/sweet-spot/archive).

_In the Sweet Spot is educational and is not investment advice or a recommendation to buy or sell any security. Figures reflect Manifest Investing's methodology as of the pick date._